204 related articles for article (PubMed ID: 20156189)
1. Lactococcus lactis as a cell factory for delivery of therapeutic proteins.
Bahey-El-Din M; Gahan CG; Griffin BT
Curr Gene Ther; 2010 Feb; 10(1):34-45. PubMed ID: 20156189
[TBL] [Abstract][Full Text] [Related]
2. Heterologous protein production and delivery systems for Lactococcus lactis.
Nouaille S; Ribeiro LA; Miyoshi A; Pontes D; Le Loir Y; Oliveira SC; Langella P; Azevedo V
Genet Mol Res; 2003 Mar; 2(1):102-11. PubMed ID: 12917806
[TBL] [Abstract][Full Text] [Related]
3. Plasmid Replicons for the Production of Pharmaceutical-Grade pDNA, Proteins and Antigens by
Duarte SOD; Monteiro GA
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573129
[TBL] [Abstract][Full Text] [Related]
4. A review on Lactococcus lactis: from food to factory.
Song AA; In LLA; Lim SHE; Rahim RA
Microb Cell Fact; 2017 Apr; 16(1):55. PubMed ID: 28376880
[TBL] [Abstract][Full Text] [Related]
5. Construction of two Lactococcus lactis expression vectors combining the Gateway and the NIsin Controlled Expression systems.
Douillard FP; Mahony J; Campanacci V; Cambillau C; van Sinderen D
Plasmid; 2011 Sep; 66(3):129-35. PubMed ID: 21807023
[TBL] [Abstract][Full Text] [Related]
6. Variations of N-acetylation level of peptidoglycan do not influence persistence of Lactococcus lactis in the gastrointestinal tract.
Watterlot L; Meyrand M; Gaide N; Kharrat P; Blugeon S; Gratadoux JJ; Flores MJ; Langella P; Chapot-Chartier MP; Bermúdez-Humarán LG
Int J Food Microbiol; 2010 Nov; 144(1):29-34. PubMed ID: 20851488
[TBL] [Abstract][Full Text] [Related]
7. Production of biological active murine IFN-gamma by recombinant Lactococcus lactis.
Bermúdez-Humarán LG; Cortes-Perez NG; L'Haridon R; Langella P
FEMS Microbiol Lett; 2008 Mar; 280(2):144-9. PubMed ID: 18248432
[TBL] [Abstract][Full Text] [Related]
8. Development of a Stress-Inducible Controlled Expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces.
Benbouziane B; Ribelles P; Aubry C; Martin R; Kharrat P; Riazi A; Langella P; Bermúdez-Humarán LG
J Biotechnol; 2013 Oct; 168(2):120-9. PubMed ID: 23664884
[TBL] [Abstract][Full Text] [Related]
9. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems.
Pontes DS; de Azevedo MS; Chatel JM; Langella P; Azevedo V; Miyoshi A
Protein Expr Purif; 2011 Oct; 79(2):165-75. PubMed ID: 21704169
[TBL] [Abstract][Full Text] [Related]
10. Heterologous protein expression by Lactococcus lactis.
Villatoro-Hernández J; Kuipers OP; Saucedo-Cárdenas O; Montes-de-Oca-Luna R
Methods Mol Biol; 2012; 824():155-65. PubMed ID: 22160898
[TBL] [Abstract][Full Text] [Related]
11. Mucosal immune responses induced by oral administration of recombinant Lactococcus lactis expressing the S1 protein of PDCoV.
Zhai K; Zhang Z; Liu X; Lv J; Zhang L; Li J; Ma Z; Wang Y; Guo H; Zhang Y; Pan L
Virology; 2023 Jan; 578():180-189. PubMed ID: 36586181
[TBL] [Abstract][Full Text] [Related]
12. Construction and expression of a heterologous protein in Lactococcus lactis by using the nisin-controlled gene expression system: the case of the PRRSV ORF6 gene.
Wang ZH; Wang YL; Zeng XY
Genet Mol Res; 2014 Feb; 13(1):1088-96. PubMed ID: 24634130
[TBL] [Abstract][Full Text] [Related]
13. Functional expression of mouse insulin-like growth factor-I with food-grade vector in Lactococcus lactis NZ9000.
Gao G; Qiao JJ; Yang CH; Jiang DZ; Li RQ; Su JJ; Xu HJ; Zhang XM; Bai YL; Qiao MQ
Lett Appl Microbiol; 2012 May; 54(5):404-9. PubMed ID: 22332956
[TBL] [Abstract][Full Text] [Related]
14. Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins.
Bermúdez-Humarán LG
Hum Vaccin; 2009 Apr; 5(4):264-7. PubMed ID: 19202351
[TBL] [Abstract][Full Text] [Related]
15. [Construction of a food-grade secretion expression vector and use it for reporter protein expression in Lactococcus lactis].
Sun Q; Xiong Y; Ye C; Xu J
Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):293-8. PubMed ID: 18479053
[TBL] [Abstract][Full Text] [Related]
16. Lactococcus lactis-based vaccines: current status and future perspectives.
Bahey-El-Din M; Gahan CG
Hum Vaccin; 2011 Jan; 7(1):106-9. PubMed ID: 21263226
[TBL] [Abstract][Full Text] [Related]
17. Expression of biologically active murine interleukin-18 in Lactococcus lactis.
Feizollahzadeh S; Khanahmad H; Rahimmanesh I; Ganjalikhani-Hakemi M; Andalib A; Sanei MH; Rezaei A
FEMS Microbiol Lett; 2016 Nov; 363(21):. PubMed ID: 27864297
[TBL] [Abstract][Full Text] [Related]
18. Production, secretion and purification of a correctly folded staphylococcal antigen in Lactococcus lactis.
Samazan F; Rokbi B; Seguin D; Telles F; Gautier V; Richarme G; Chevret D; Varela PF; Velours C; Poquet I
Microb Cell Fact; 2015 Jul; 14():104. PubMed ID: 26178240
[TBL] [Abstract][Full Text] [Related]
19. M cell-targeting strategy enhances systemic and mucosal immune responses induced by oral administration of nuclease-producing L. lactis.
Takahashi K; Yano A; Watanabe S; Langella P; Bermúdez-Humarán LG; Inoue N
Appl Microbiol Biotechnol; 2018 Dec; 102(24):10703-10711. PubMed ID: 30310964
[TBL] [Abstract][Full Text] [Related]
20. [High-level expression of phenylalanine ammonia-lyase in Lactococcus Lactis via synthesized sequence based on bias codons].
Chen X; Gao B; Jia XY; Su C; Lü YP; Wang ZY; Fan XP; Xiao B; Liu JZ
Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):187-90. PubMed ID: 16607941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
